Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Early Phase 1
1(50.0%)
Phase 4
1(50.0%)
2Total
Early Phase 1(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT01427426Phase 4Completed

Does a Nutritional Supplement Increase Vitality, Energy and Perceived Well Being?

Role: collaborator

NCT00783991Completed

Investigating the Impact of Mode of Administration on Item Response

Role: collaborator

NCT00786227Completed

Initial Validation of PROMIS Physical Function/Disability Scales in Rheumatoid Arthritis (RA)

Role: collaborator

NCT01059487Early Phase 1Unknown

Bringing Acute and Wellness Care to Underserved Populations Using Traditional Chinese Medicine

Role: collaborator

All 4 trials loaded